Lotus Pharmaceutical Co., Ltd. (TPE:1795)
Taiwan flag Taiwan · Delayed Price · Currency is TWD
208.50
-3.50 (-1.65%)
At close: Mar 26, 2026

Lotus Pharmaceutical Ratios and Metrics

Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
54,79674,42371,52471,93564,46225,569
Market Cap Growth
-24.77%4.05%-0.57%11.59%152.11%30.27%
Enterprise Value
94,53281,17080,27681,66671,66030,851
Last Close Price
208.50283.00262.47260.17232.5690.84
PE Ratio
11.5615.7714.1217.5221.3418.22
Forward PE
12.3911.0512.0515.3618.3915.41
PS Ratio
2.673.633.854.244.412.02
PB Ratio
2.303.133.384.154.652.31
P/TBV Ratio
--7.2611.6528.1410.18
P/FCF Ratio
8.8912.0812.3359.7720.52-
P/OCF Ratio
7.329.9511.6244.5617.33213.68
EV/Sales Ratio
4.613.964.324.824.902.44
EV/EBITDA Ratio
12.2210.6710.9513.2314.079.63
EV/EBIT Ratio
15.2313.0812.9916.0716.8612.20
EV/FCF Ratio
15.3413.1713.8467.8522.81-
Debt / Equity Ratio
2.002.000.650.670.640.63
Debt / EBITDA Ratio
6.146.141.831.841.722.12
Debt / FCF Ratio
7.707.702.369.632.84-
Net Debt / Equity Ratio
1.671.670.360.570.500.48
Net Debt / EBITDA Ratio
5.225.221.041.591.361.67
Net Debt / FCF Ratio
6.456.451.328.152.21-11.78
Asset Turnover
0.280.280.510.540.580.62
Inventory Turnover
1.281.282.012.132.132.65
Quick Ratio
0.920.921.631.851.171.16
Current Ratio
1.571.572.152.801.811.93
Return on Equity (ROE)
21.00%21.00%26.30%26.32%24.23%14.16%
Return on Assets (ROA)
5.30%5.30%10.57%10.16%10.47%7.71%
Return on Invested Capital (ROIC)
11.09%11.10%17.59%17.05%17.51%12.44%
Return on Capital Employed (ROCE)
7.00%7.00%19.50%17.90%18.00%15.00%
Earnings Yield
8.61%6.34%7.08%5.71%4.69%5.49%
FCF Yield
11.25%8.28%8.11%1.67%4.88%-1.77%
Dividend Yield
1.21%0.91%2.18%1.79%1.49%2.13%
Payout Ratio
32.20%32.20%24.32%22.07%16.75%6.56%
Buyback Yield / Dilution
0.67%0.67%-0.53%-0.13%-1.95%-5.43%
Total Shareholder Return
1.93%1.57%1.66%1.66%-0.46%-3.30%
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.